6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
F-1: Registration statement for securities of certain foreign private issuers
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
F-1: Registration statement for securities of certain foreign private issuers
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Psyence Biomedical | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Psyence Biomedical | 8-K: Current report
Newcourt Acquisition Corp | 8-K: Current report
Newcourt Acquisition Corp | 8-K: Current report
No Data
No Data